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A b s t r a c t .  Physical dependence on ethanol was pro- 
duced in four rhesus monkeys by IV ethanol adminis- 
tration every 8 h. Ethanol was administered on each 
occasion until the eyeblink reflex was lost. Evidence of 
physical dependence development, in the form of 
tremoring 8 h after an infusion, appeared on day 8 of 
chronic administration. Abrupt cessation of ethanol 
administration following 16 days of  chronic adminis- 
tration was accompanied by moderate to severe tremor- 
ing, retching, vomiting, and one or more convulsions. 
Peak withdrawal occurred between 12 and 32 h after 
abrupt discontinuation of ethanol administration, and 
decreased over a period of 6 4 - 2 0 4  h. Ethanol de- 
pendence was then reinstated. Once every 3 - 4  days, 
ethanol was withheld for 16 h. Withdrawal signs were 
scored for the first 12 h of  this period, and then a test 
dose of ethanol, phenobarbital, or baclofen was admin- 
istered. Withdrawal or intoxication signs were scored 
over the next 4 h, at which time ethanol administration 
w a s  resumed. Both ethanol and phenobarbital sup- 
pressed ethanol withdrawal signs in a dose-related 
manner, and produced dose-related intoxication. 
Baclofen was largely ineffective in reducing 
withdrawal-induced tremors, although it was capable 
of producing sedation of a different type than that 
produced by phenobarbital and ethanol. 
K e y  words :  Ethanol physical dependence - 
P h e n o b a r b i t a l  - Baclofen - Rhesus monkey 
The production of physical dependence on ethanol in 
a n i m a l s  has proven useful in testing the effects of a 
variety of  drugs on ethanol withdrawal signs. Several 
investigators have used ethanol-dependent animals to 
study drugs which are used clinically for the treatment 
Offprint requests to." Gail Winger, Department of Pharmacology, 
M6322 Medical Science Building I, University of Michigan, Ann 
Arbor, MI 48109, USA 
of ethanol withdrawal (Essig et al. 1969; Goldstein 
1972; Sprague and Craigmill 1976). Others have tested 
drugs that are known to interfere with certain neuro- 
transmitters in the brain (Goldstein 1973, 1979; Cooper 
et al. 1979). Still others have searched for drugs that can 
specifically suppress withdrawal signs without produc- 
ing generalized CNS depression or untoward side 
effects (Majchrowicz 1976; Noble et al. 1976). 
Although the data provided by these studies have been 
uniformly interesting and useful, there were some 
disadvantages in each. In most cases, rats or mice were 
experimental subjects, and the withdrawal sign scored 
was usually convulsions produced by handling or by 
sound, a sign with no clear counterpart in humans. 
Also, quantitative evaluation of the direct effect of the 
treatment drug on behavior has rarely been made, so 
that it is difficult to determine the amount  of  sedation 
that accompanies the observed drug effect on ethanol 
withdrawal signs. 
In an attempt to overcome these disadvantages, we 
used rhesus monkeys as subjects in an experiment 
designed to evaluate the effect of three drugs on ethanol 
withdrawal. Ethanol dependence in monkeys has been 
produced by several investigators (Ellis and Pick 1970; 
Pieper et al. 1972; Pieper and Skeen 1972) and with- 
drawal has been shown to resemble closely the early 
phases of withdrawal in humans. In this study we 
measured tremor as our indicator of withdrawal, a 
measure with a direct counterpart in humans. In 
addition, we also recorded, in a quantitative manner, 
the sedation produced by the test drugs. This indication 
of  the severity of drug-induced impairment which may 
accompany attenuation of withdrawal would be helpful 
in selecting an agent which might relieve withdrawal 
with the least amount of incapacitation. 
The technique used was a modification of one used 
in similar studies of narcotic dependence (e.g., 
Himmelsbach and Andrews 1943). Physical depen- 
dence was produced by chronic drug administration; 
deprivation-induced withdrawal was interrupted at 
0033-3158/80/0070/0201/$01.60 
202 Psychopharmacology 70 (1980) 
ce r t a in  po in t s  by a d m i n i s t r a t i o n  o f  a test  drug.  T h e  
p r e c e d i n g  h o u r s  o f  w i t h d r a w a l  were  used  to d e t e r m i n e  
the  cu r r en t  d e p e n d e n t  s tate ,  a n d  the effect  o f  the  test  
d r u g  on  this s ta te  c o u l d  be  eva lua ted .  
T h r e e  d rugs  were  assessed as to the i r  e f f icacy  in 
suppress ing  the  e t h a n o l - w i t h d r a w a l  s y n d r o m e .  T h e  
d rugs  were  e thano l ,  p h e n o b a r b i t a l ,  a n d  bac lofen .  
E t h a n o l  a n d  p h e n o b a r b i t a l  a re  k n o w n  to  reverse  
e t h a n o l  w i t h d r a w a l  in m a n  a n d  in m a n y  a n i m a l  m o d e l s  
o f  e t h a n o l  dependence .  T h e y  were  used  to  tes t  the  
ef f icacy o f  this  test  design,  a n d  its c o m p a r a b i l i t y  to 
o the r  tests o f  d r u g  effects  on  e t h a n o l  w i thd rawa l .  
Bac lo fen  [ b e t a - ( 4 - c h l o r o p h e n y l ) - g a m m a - a m i n o b u t y r i c  
acid] is a de r iva t ive  o f  the  p u t a t i v e  n e u r o t r a n s m i t t e r  
g a m m a - a m i n o b u t y r i c  acid. Its s t ruc tu ra l  s imi la r i ty  to  
G A B A  or ig ina l ly  sugges ted  tha t  its ac t ions  m i g h t  be  
r e l a t ed  to  a c t i v a t i o n  o f  the  G A B A  recep tor .  A l t h o u g h  
e l ec t rophys io log i c  a n d  b i o c h e m i c a l  ev idence  h a v e  in- 
d i ca t ed  tha t  by a n d  large,  b a c l o f e n  does  n o t  ac t  d i rec t ly  
on  the  G A B A  r e c e p t o r  ( N a i k  e t  al. 1976), r ecen t  
b e h a v i o r a l  d a t a  ind ica te  t ha t  it m a y  h a v e  a w e a k  
G A B A  agon i s t  effect ,  at  leas t  in s o m e  par t s  o f  the  b r a i n  
( W a d d i n g t o n  a n d  Cross  1979). T h e  c u r r e n t  in te res t  in 
the  poss ib i l i ty  t ha t  a l t e ra t ions  in the  G A B A e r g i c  
sys tem m a y  p r o d u c e  m a r k e d  changes  in e t h a n o l  wi th -  
d r awa l  ( G o l d s t e i n  1973, 1979; C o o p e r  1979; N o b l e  et  
al. 1976) inc reased  o u r  in te res t  in i nves t i ga t i ng  
bac lofen .  
Bac lo fen  was  in te res t ing  a lso  because  it  is useful  
c l inical ly  in t r e a t m e n t  o f  spas t ic i ty  a n d  spasms  
(Pedersen  et  al. 1970; H u d g s o n  a n d  W e i g h t m a n  1971 ; 
B r o g d e n  e t  al. 1974). Spas t ic i ty  is o n e  o f  the  signs o f  
e t h a n o l  w i t h d r a w a l  t ha t  has  been  o b s e r v e d  in m o n k e y s  
(Ellis a n d  P ick  1970) F u r t h e r m o r e ,  b a c l o f e n  has  been  
r e p o r t e d  to  r educe  the signs o f  m o r p h i n e  w i t h d r a w a l  in 
mice  ( R o b s o n  et  al. 1977) a l t h o u g h  it  has  no  k n o w n  
n a l o x o n e - r e v e r s i b l e  n a r c o t i c  effects.  T h e  poss ib i l i ty  
t ha t  b a c l o f e n  m i g h t  be  able  to  r educe  ' w i t h d r a w a l '  in 
genera l  was  an  in te res t ing  one.  
Materials and Methods 
Subjects. Four male rhesus monkeys (Macaca mulatta) weighing 4 -  
5 kg served in all experiments. Each animal was surgically implanted 
with a chronic indwelling jugular catheter exiting at a midscapular site 
and passing through a harness and restraining arm to the exterior of 
the cage (Deneau et al. 1969). The monkeys were housed individually 
in cages 94 • 94 • 94 cm.They were allowed free access to Purina 
Monkey Chow and water and were given assorted fruits and grains 
daily. During chronic ethanol administration, food intake decreased 
and diet was occasionally supplemented with 50-150 ml Sustagen (4 
tablespoons/100 ml water) via gastric intubation through the nasal 
passage. In addition, drinking water was occasionally supplemented 
with Tang (1 tsp/500 ml). 
Preliminary Experiments. Prior to catheterization and any ethanol 
administration, single observations of the effects of IM adminis- 
tration of various doses of baclofen and phenobarbital were made in 
order to select two doses of each drug for testing in the withdrawal 
experiments. 
First, baclofen, in doses of 1.0, 3.0, and 10.0 mg/kg and saline 
were administered IM, one dose per monkey. Observations were 
subsequently made at 3, 10, 30, 100, and 300 min. Three days later, 
5.6 mg baclofen/kg body weight was given to the monkey who had 
previously received saline and observations were made at the time 
intervals listed above. Then, phenobarbital, in doses of I0, 30, and 
56 mg/kg, and saline were administered IM, again, one dose per 
monkey, and the animals were monitored as above. 
Ethanol Administration and Withdrawal. Animals were made physi- 
cally dependent on ethanol by administration of 27.5 % (w/v) ethanol 
every 8 h: 8 a.m., 4 p.m., and 12 midnight. The ethanol was infused 
through the IV catheters using Sage Model 249-2 pumps. Infusion 
speed varied slightly according to the resistance of an individual 
animal's catheter, but averaged approximately 1.0 ml/min. Each 
animal received enough ethanol to produce loss of the eyeblink reflex 
when the eyelid was touched. Observations were made both immedia- 
tely prior to and 5 min following each ethanol administration. During 
this initial phase, ethanol was given three times daily for 16 days 
(period 1). 
Withdrawal consisted of the period of time from the last dose of 
ethanol until all signs of withdrawal disappeared. Observations 
began 8 h after the last dose of ethanol and were made at 0, 10, 30, 
100, and 300 min every 8 h until withdrawal began to subside. 
Thereafter, obervations were made at 8-h intervals, and later at 24-h 
intervals until all withdrawal signs disappeared. 
After withdrawal was complete in all animals, 7 days elapsed 
before ethanol administration was resumed. 
The Effects of  Baclofen and Phenobarbital on Ethanol Withdrawal. 
Ethanol was administered chronically (period 2) according to the 
procedure described above, with the addition that, following the first 
administration, a limit of 3 g/kg was placed on each ethanol injection. 
On day 8 of period 2, the scheduled 8 a.m. dose of ethanol was 
omited. Starting at that time, 8 h after the last dose of ethanol, the 
animals were observed for withdrawal signs at 0, 10, 30, 100, and 
210-240 rain. Baclofen or phenobarbital was given immediately 
following the last observation (i.e., 12h after the last ethanol 
injection) and observations of the monkeys were made at 10, 30, and 
100 min following drug administration. The doses of phenobarbital 
used were 10.0 and 30.0 mg/kg and the doses of baclofen were 30 and 
5.6 mg/kg; volume was 0.2 ml/kg. Each monkey received both doses 
of both drugs and saline. Order of administration was determined by 
a modified Latin square design. At 4 p.m., 16 h after the last dose of 
ethanol, ethanol administration was resumed according to schedule. 
This sequence was repeated every 2 - 3  days. 
After the 17th day of chronic ethanol administration, the 
monkeys appeared quite debilitated, and it was decided to disconti- 
nue ethanol administration temporarily. The animals went through 
complete withdrawal and were observed according to the procedure 
described previously. After withdrawal was complete, 12 days 
elapsed, then chronic administration of ethanol was begun again 
(period 3). On day 11 of this period, the 8 a.m. ethanol dose was 
omitted, and following 240 min of withdrawal, a test dose of 
baclofen, phenobarbital, or saline administered. After this, ethanol 
administration was resumed according to schedule, as baselines for 
the evaluation of the effects of ethanol on ethanol withdrawal. 
The Effects of Ethanol on Ethanol Withdrawal. On day 14 of period 3, 
the first test dose of ethanol was administered IV through the same 
pump system that administered the chronic ethanol_ On each test day, 
after the omitted ethanol infusion and after ethanol injection, 
observations were made at 0, 60, and 210-240 rain. Three doses of 
ethanol were tested: 0.3, 1.0, and 1.8 g/kg. 
Observations. In all experiments, a grading sheet was used to assess 
and record the individual animals' behavior. The sheet included 
behaviors observed with some frequency following administration of 
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baclofen, phenobarbital, ethanol, and ethanol withdrawal. Several of 
the items were recorded simply as present or absent: fasciculatJon, 
piloerection, salivation, eating, retching, vomiting. Two items were 
recorded by the direction of change: apprehension and aggression 
and three items were graded on a four-point scale: muscle weakness, 
ataxia, and tremor. Additional observations and comments were 
noted at the bottom of each sheet. 
Muscle weakness was scored in the following way: 0 = none; 1 
= limp wrist or droopy head, or slight difficulty standing; 
2 = definite difficulty standing or holding onto side of cage or sitting 
with head between knees; 3 = sitting in cage but requiring support 
(harness, side of cage) to keep from falling over; 4 = lying in cage, 
unable to sit. 
The scoring system used for ataxia was the following: 0 = none; 
1 = slightly staggered walk or slow reaction time; 2 = definite 
staggered walk, lack of coordination or slow reaction time; 
3 = cannot keep balance when standing; 4 = lying in cage unable to 
sit or stand. Following a high dose of test drug, it was occasionally 
difficult to distinguish severe ataxia from severe muscle weakness; in 
such cases, animals were given scores of 4 for both. 
Tremors were rated according to the following scale: 0 = none; 
1 = fine tremor of hand or legs with volitional movement (standing, 
grasping, grooming); 2 = resting tremor (head, hand), gross tremor- 
ing with movement; 3 = hand tremoring too much to grasp or hold 
food, barely able to walk due to leg shaking; 4=  spontaneous 
episodes of violent, gross shaking, near convulsion, unable to move 
without whole bocly shaking uncontrollably. 
All observations following test drugs, including ethanol, were 
made by two observels. In the case of administration of baclofen, and 
phenobarbital, both observers were blind as to the close and the drug 
administered. In the case of the ethanol administration, since it was 
given by itself later in the protocol and was given by a different route, 
both observers were aware that ethanol was being administered. 
However, the dose administered was not known, and it was not 
known which animal received saline. Daily observations of the 
monkeys before and after each ethanol infusion were also made by 
two observers at 8 am. and 4 p.m. A single observer recorded the 
information at midnight. 
Blood Ethanol. On the last day of chronic ethanol periods I and 2, 
blood samples were drawn from each monkey and analyzed for 
ethanol content. Samples were taken at three times: immediately after 
the termination of the ethanol infusion, i.e., when the monkey was 
unconscious; 3 h after the infusion; and just before the next infusion, 
8 h after the previous ethanol administration. Blood was drawn from 
the saphenous vein of three of the monkeys, and from the catheter of 
the fourth monkey. 
Samples were analyzed for ethanol content using a gas 
chromatograph with isopropyl ethanol as the internal standard. 
Drugs. Baclofen was first dissolved in 0.5 ml of 1N NaOH. Two 
milliliters of saline were added and the solution was titrated to pH 
= 9 with 1N HCI. Phenobarbital was dissolved in distilled water. 
Both drugs were administered intramuscularly at 0.2 ml/kg, accord- 
ing to each individual's weight. 
Ethanol, in all cases, was a 275 ~ (w/v) solution of 95 ~ ethanol 
in saline and was administered IV. 
Results 
Preliminary Experiments. Baclofen doses of 1.0 and  
3 . 0 m g / k g  had no observable effects; 5.6 and 
10 .0mg/kg  baclofen produced increases in muscle 
weakness scores and  the animals  appeared to be 
sedated. Wri t ten  comments  about  these animals  in- 
cluded: "dozes off if left alone;  falls over while 
crouching;  cannot  lock straight ahead for a long time 
- eyes droop;  holds on to  side of  cage; has 'b l ind '  
look."  The two doses, 5.6 and  10.0 mg/kg were equally 
effective for the first 30 min ;  thereafter, 10.0 mg/kg had 
a greater effect. 
The phenobarb i ta l  dose of 10 mg/kg produced no 
observable effects. Fol lowing adminis t ra t ion  of 30 and  
56 mg/kg, animals  showed increases in ataxia and  
decreases in aggression and  apprehension.  A n i m a l s  
were described as ' losing balance easily; falling over 
while sitting; staggering quite a bit  when walking. '  The 
two doses were equally effective for the first 30 min ;  
after that, 56 mg/kg had a greater effect. 
For  use in e thanol  withdrawal  experiments,  two 
doses of each drug were chosen:  the highest dose of 
each drug that  had no observable effects, and  the lowest 
dose that  produced marked  effects. The doses selected 
were 3.0 mg/kg and  5.6 m s / k s  baclofen and  10 mg/kg 
and  30 mg/kg phenobarbi ta l ,  
Ethanol Administration and Withdrawal. To produce 
physical dependence, e thanol  was administered three 
times daily for 16 days (period 1). Dur ing  an  ethanol  
infusion, animals  displayed typical signs of intoxi- 
cation. They were initially ataxic and  responded more 
slowly than usual  to being approached by experimen- 
ters. As more e thanol  was administered,  occasional 
vomit ing or retching occurred. The animals  grew 
increasingly sedated to the point  that  they sat mot ion-  
less with their eyes shut and  seemed to go to sleep. 
Eventual ly  they fell over in their cages and  became 
comatose, failing to exhibit an eyeblink reflex. 
The a m o u n t  of e thanol  required to produce loss of 
the bl ink reflex increased gradual ly over the entire 
per iod of administration_ For  the first week (days 1 - 
8), the average a m o u n t  of e thanol  necessary to produce 
a loss of eyeblink reflexes was 1.55 _+ 0.7 g/kg, and  for 
the last 7 days (day 1 0 - 1 6 ) ,  it was 2.04 _+ 0.5 g/kg. 
Figure 1, top panel,  shows amounts  of ataxia and  
t remor observed before each ethanol  adminis t ra t ion,  
8 h after the previous dose of ethanol,  in period 1. 
Dur ing  the first 8 days, average pro-injection ataxia 
scores generally declined; by the n in th  day, pre- 
injection ataxia was negligible. Pro-injection t remoring 
began to appear on the eighth day of period 1 and 
t remor scores increased gradually for the remainder  of 
the period. 
Th roughou t  the course of chronic adminis t ra t ion,  
food intake was reduced. The animals  ate no chow and  
only occasionally fruit or grain. Weight loss, measured 
from day 1 to day 16, averaged 0.62 _+ 0.06 kg for the 
four monkeys  during period 1. 
By 8 h after the last dose of ethanol,  the average 
t remor  score was 1.25. Dur ing  the next 4 h, t remor  
scores increased rapidly and  by the 12th hour  of 
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Fig. 1. Effects of ethanol 8 h after administration for three chronic administration periods. The ordinate represents average ataxia (-e-) and 
tremor (--OQ scores. The abscissa shows time of observation in days. Ethanol was administered three times daily, at 8 a.m., 4 p.m., and 12 
midnight; thus each point represents an observation made before each administration of ethanol, or 8 h after the previous dose. Top panel chronic 
administration period 1 ; middle panel chronic administration period 2; bottom panel chronic administration period 3. Breaks in the graphs in the 
middle and bottom panels represent days when an ethanol administration was omited and test drugs were given. Tremor scores prior to the time 
they appear on the graphs were all 0. Points represent means for four animals; brackets signify + I SE 
withdrawal, the average was 3.0. Convulsion, which 
were seen in three of the four animals, all occurred 
between 11 and 15 h after the last dose of  ethanol. 
Withdrawal peaked, in general, at 1 2 - 2 4  h and tremor 
scores gradually declined for the remainder of the 
withdrawal period. Withdrawal signs had completely 
disappeared by 64 h in one animal, 84 h in another, and 
204 h in the other two monkeys. 
In three monkeys, episodes of  1 0 - 1 5  s of severe 
shaking (tremor score = 3 - 4 )  were seen at 9 . 5 - 1 2  h 
after the last dose of ethanol. The shaking increased in 
frequency to the point that, by 13 and 15 h respectively, 
each animal was lying on the floor of his cage in a 
'spread eagle' position, gripping the floor tightly with 
hands and feet. Tremoring became even more violent, 
and apparently uncontrollable, if the animal attempted 
to move. One of these monkeys had a single full-scale 
convulsion which appeared after several seconds of 
severe shaking. Another monkey had nine convulsions 
and was given 0.2 mg/kg diazepam IV. His tremor 
scores were reduced for 2.5 h and then increased again, 
but no further convulsions were observed. 
The fourth monkey never showed the degree nor the 
frequency of the tremulousness and shaking episodes 
that the other three showed. Throughout  withdrawal, 
this animal was able to sit quietly, for the most  part, 
with his eyes closed, although alert and apprehensive in 
response to noise. I f  provoked, he became tremulous 
(tremor score = 2 - 3 ) .  This monkey had one convul- 
sion, 13 h after the last dose of  ethanol. 
Chronic Ethanol in Periods 2 and 3. On the first injection 
of the second period of chronic ethanol administration, 
an average of 4.9 g/kg ethanol was required to produce 
loss of eyeblink. This caused such marked and long- 
lasting intoxication that  the second infusion was omit- 
ted. Thereafter, each infusion was limited to no more 
than 3 g/kg. The amount  of ethanol given increased 
progressively over the second period from an initial 
level of 2.10 + 0.13 g/kg for days 2 -  7 to a maximum of 
2.48 _+ 0.14 g/kg for the final 3 days (days 15-17) .  
Figure 1, second panel, shows average ataxia and 
tremor scores taken during period 2, 8 h after each dose 
of ethanol. Ataxia scores declined gradually over the 
first part  of  the period and remained low after day 8. 
Tremors began to appear prior to ethanol adminis- 
tration on day 4 and tremor scores increased over the 
period. 
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Fig. 2 
Effects of baclofen on ethanol withdrawal. 
Top panel tremor scores; bottom panel muscle 
weakness scores. The ordinate shows average 
score and the abscissa shows time, in minutes, 
relative to baclofen administration. Baclofen 
administration occurred at time 0, as indicated 
by the arrow, 12 h after the last dose of ethanol. 
Data points to the left of time 0 represent mean 
scores for all animals prior to receiving saline, 
3.0 mg/kg baclofen, or 5.6 mg/kg baclofen 
(N = 12); data points to the right of  time 0 
represent means for four animals on a single dose 
(N = 4). [] Saline; 9 3.0 mg/kg baclofen; 
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Four interruptions in ethanol administration occur- 
red during period 2, on days 8, 11, 15, and 18. These 
were the days on which doses of phenobarbital and 
baclofen were tested. On day 18 of  period 2, when test 
day 4 occurred, ethanol administration was terminated 
and the animals went through extended ethanol with- 
drawaL After an 8-day withdrawal period, 12 days 
elapsed, then period 3 was begun. As with period 2, the 
average of amount of ethanol necessary to produce loss 
of the blink reflex increased gradually over the period. 
For  days 2 - 1 0 ,  the average was 2.13 + 0.05 g/kg; for 
days 2 0 - 2 2 ,  it was 2.55 _+ 0.11 g/kg. Figure 1, bottom 
panel, depicts average ataxia and tremor scores for 
period 3. Ataxia scores decreased over the first part of 
the period, and in period 2, and remained low after day 
11 with slight increases at the end of the period. 
Tremors appeared on day 10 in all but one animal. 
Tremor scores increased over a 7-day period (days 1 0 -  
18), then appeared to stabilize. In period 3, as well as in 
period 2, the ataxia observed 8 h after each dose of 
ethanol failed to disappear altogether despite the fact 
that tremors began to develop. We were frequently able 
to observe ataxia and tremors in the same monkey at 
the same time. 
Period 3 was interrupted five times. The first 
interruption, day 11, occurred when the final test of 
phenobarbitol or baclofen effects was conducted. The 
next four times, days 14, 17, 20, and 22, occurred when 
ethanol's effects on ethanol withdrawal were evaluated. 
The Effects of  Baclofen, Phenobarbital, and Ethanol on 
Ethanol Withdrawal. Figure 2 shows the effects of 
baclofen on ethanol withdrawal. Baclofen, at 3.0 and 
5.6 mg/kg, produced only a slight reduction in tremor 
scores. The dose of 3.0 mg/kg, which had no effect in 
these monkeys before ethanol administration and with- 
drawal, now caused increases in muscle weakness 
scores and sedation. The monkeys were observed to be: 
*falling asleep sitting hunched over; barely holding 
himself up; drooping eyes.' With both doses of bac- 
lofen, several monkeys showed increases in aggressive- 
ness. Four  hours after administration (15 h after the 
last dose of ethanol), 3.0 mg/kg baclofen failed to 
prevent convulsions in one monkey. No convulsions 
were seen following either 5.6 mg/kg baclofen or saline. 
Figure 3 shows the effects of phenobarbital on 
ethanol withdrawal. Both doses of phenobarbital were 
successful in reducing tremor scores somewhat for up to 
4 h. The 10 mg/kg dose produced more tremor re- 
duction than baclofen only at 30 min following the 
injection. The higher dose was more effective and had a 
longer duration of action than the lower dose. The dose 
of 10 mg/kg produced ataxia in one animal and some 
signs of sedation in all animals. The dose of 30 mg/kg 
produced moderate ataxia and sedation in all animals. 
Both doses failed in several cases to reduce the predrug 
increases in apprehension and aggression. No convul- 
sions occurred following either dose of phenobarbital 
or saline. 
In Figure 4, the effects of  three doses of ethanol and 
saline on ethanol withdrawal are shown. The lowest 
dose of ethanol, 0.3 g/kg, was only slightly effective in 
reducing tremor scores. It also produced little or no 
ataxia and had no effect on increases in apprehension 
and aggression. Two animals had convulsions after 
receiving this dose, one after 90 rain (13 h after ethanol 
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Fig. 4. The effects of ethanol on ethanol withdrawal. Top panel 
tremor scores; bottompanel ataxia scores. See the caption of Figure 2 
for further details. [] Saline; 9 0.3 g/kg ethanol; 9 1.0 g/kg ethanol; 
9 1.8 g/kg ethanol. Brackets signify _+ 1 SE 
withdrawal) and one after 225 min (15 h after ethanol 
withdrawal). In contrast, both 1.0 g/kg and 1.8 g/kg 
ethanol immediately suppressed tremors completely. 
After 10 rain, 1.8 g/kg was more effective than 1.0 g/kg 
in suppressing tremors, although with the latter, tremor 
scores remained below predrug levels for at least 3 h. 
Both the 1.0 and 1.8 g/kg doses of ethanol produced 
ataxia and sedation, the higher dose having a severe 
effect for several hours. One monkey had convulsions 
180 min after receiving 1.0 g/kg ethanol (14.5 h after 
ethanol withdrawal) where none was seen after 
1.8 g/kg. The inter-observer correlations for obser- 
vations of tremor was 0.91, and for observations of 
direct effects (ataxia and muscle weakness) was 0.84. 
Blood Ethanol. Blood samples drawn from each 
monkey on the last day of ethanol administration of 
periods 1 and 2 revealed a mean blood alcohol level of 
227.5 + 21.4 mg/100 ml of blood. The average blood 
ethanol level for the monkey whose sample was drawn 
from the catheter was slightly higher than the average 
levels in blood taken from the saphenous vein 
(259 rag/100 ml vs. 217 mg/100 ml). This may have 
been due to residual ethanol in the catheter. The 
monkeys were unconscious at the time this sample was 
drawn, due to the immediately prior administration of 
ethanol. The average blood ethanol level was 156.4 +_ 
21.6 mg/100 ml of blood at 3 h after the infusion and 
103.1 + 15.3mg/100ml of blood at 8h  after the 
infusion. Average rate of ethanol disappearance was 
17.9 mg/100 ml/h. Thus, if these data are typical, there 
was ethanol remaining in the blood 8 h after the final 
infusion. The observations of ataxia, 8 h after injections 
early in each period, give behavioral credence to this 
finding. There was no differences in either peak blood 
ethanol level or ethanol disappearance rate from the 
end of period 1 to the end of period 2. 
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Discussion 
Withdrawal from ethanol in primates has been de- 
scribed in some detail by Deneau et al. (1969), Ellis and 
Pick (1970), Pieper and Skeen (/972), Pieper et al. 
(1972), and Winger and Woods (1973). For the most 
part, the data presented here have substantiated these 
reports and parallel the descriptions of ethanol with- 
drawal in humans (Isbell et al., 1955; Victor and Adams 
/953; Mendelson and La Dou 1964). Tremulousness, 
increased apprehension and aggression, anorexia, 
vomiting, and retching were the salient features of the 
initial phases of withdrawal. At the peak of withdrawal, 
severe preconvulsive behavior was seen in three 
monkeys and convulsions were observed in all four 
monkeys. Thus, with the exception of delirium tremens, 
the major aspects of ethanol withdrawal, as they have 
been described in humans, were evident in our animals, 
supporting the value of using primates in studies of 
ethanol dependence. 
Previous investigators have found that drugs that 
are pharmacologically related to ethanol are effective in 
relieving the ethanol withdrawal syndrome. Ethanol 
itself is very effective in suppressing ethanol abstinence 
signs (Ellis and Pick 1970; Goldstein 1972; Blum et al. 
1976; Sprague and Craigmill 1976); however, it is 
reported to be of limited use clinically because of its 
narrow margin of safety and short duration of action 
(Isabell et al. 1955; Golbert et al. 1967). Of the drugs 
tested in these studies, ethanol was the most effective in 
reversing withdrawal signs; however, it did so only at 
doses which produced moderate to severe ataxia, and 
even at the highest dose, it had a relatively short 
duration of action. Phenobarbital, which has a longer 
duration of action, has been reported by Goldstein 
(1972) to relieve ethanol abstinence signs in mice for 
long periods of time; it has also been used by Isbell et al. 
(1955) to treat humans in severe ethanol withdrawal. In 
the present experiments, phenobarbital successfully 
reduced the severity of withdrawal for the entire test 
period and produced moderate amounts of ataxia and 
sedation only at the higher dose. Baclofen, despite the 
fact that it produced a general sedation, was not as 
useful in suppressing ethanol withdrawal tremors. The 
slight amount of tremor suppression observed was 
accompanied by considerable muscle weakness and 
increased apprehension and aggression. It appears that 
the sedative effects of baclofen are unrelated to those of 
the barbiturates of ethanol. 
Goldstein (1979) has reported that IP administered 
muscimol, a GABA receptor agonist, has no effect on 
ethanol withdrawal convulsions in mice. Cooper et al. 
(1979) found that muscimol, as well as GABA itself, 
when given IV were active in reducing sound-induced 
convulsions in ethanol withdrawn rats. Other 
GABAergic compounds have also been shown to 
reduce withdrawal signs in rodents (Goldstein 1973). 
Our observations show that baclofen does not protect 
against withdrawal-induced tremoring in monkeys, 
indicating that baclofen, at least when given IM, may 
not have GABAergic effects centrally. 
In the experiments reported here, ethanol de- 
pendence developed after only 7 -16  days of chronic 
administration. This corroborates the findings of Ellis 
and Pick (1970) that only 10-  18 days were necessary 
initially to produce physical dependence, and in sub- 
sequent cycles, as few as 5 days were required. It has 
been suggested that, in general, animals with previous 
histories of ethanol withdrawal require less exposure to 
ethanol to reproduce ethanol dependence (Branchey et 
al. 1971). Our results, however, did not necessarily bear 
this out. Signs of withdrawal, i.e., tremors, appeared 
after 8 days in the first period of chronic adminis- 
tration, and after 4 days in the second, but not until 
after 10 days in the third. This was remarkably uniform 
among animals in that, with the exception of one 
monkey in the third period, all animals showed first 
signs of tremoring within 48 h of one another. 
Goldstein (1974) has reported that if insufficient time is 
allowed between cycles of intoxication, recovery will be 
incomplete and ethanol dependence will carry over 
from one cycle into the next. Since less time elapsed 
between chronic administration periods 1 and 2 than 
between 2 and 3, the most plausible explanation for our 
results is that there was an acumulation or carry over of 
physical dependence from period 1 to period 2 but not 
from period 2 to period 3. 
Our observations of the simultaneous occurrence of 
tremors and ataxia have not, to our knowledge, been 
reported previously, although it is well known that 
ethanol withdrawal can occur following a decline in 
ethanol blood levels, but while these blood levels are 
still substantial. 
Several investigators have reported evidence of 
tolerance developing during chronic ethanol adminis- 
tration (Isbell et al. 1955; Mendelson and La Dou 1964; 
Ellis and Pick 1970; Falk et al. 1972; Pieper and Skeen 
/972; Pieper et al. 1972). In agreement with these 
findings, our results demonstrated the development of 
tolerance in two different ways. First, within each 
period, the amount of ethanol given to the animals to 
produce loss of the eyeblink reflex gradually increased 
from beginning to end. Second, the ataxia observed 8 h 
after each dose of ethanol decreased over time within 
each period (Fig. 1). Kalant et al. (1971) have suggested 
that the appearance of withdrawal signs in the intervals 
between doses may mean the duration of the effect of 
each dose is diminishing. Thus, the appearance of 
tremors and the decreases in ataxia could have been 
indicative of decreases in the duration of action of each 
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dose of ethanol,  that  is of development  of metabolic  
tolerance. Decreases in pre-inject ion ataxia developed 
rapidly within the first several days of each chronic 
adminis t ra t ion  period, well before physical dependence 
was apparent ,  suggesting that  this type of tolerance 
may be independent  of physical dependence. 
The experiments described here have demonstra ted 
the successful use of a technique for repeated evaluat ion 
of the effects of drugs on the e thanol-withdrawal  
syndrome in primates. Physical dependence was pro- 
duced in a relatively short a m o u n t  of time and  main-  
ta ined for extended periods despite recurrent  inter- 
rupt ions  for testing the effects of drugs on withdrawal.  
In  addit ion,  repeated episodes of the withdrawal  signs 
were successfully produced so that  several doses of 
several drugs could be tested in the same subject during 
chronic administrat ion.  Observat ions of the direct 
effect of the administered drug, in addi t ion to its effect 
on withdrawal- induced t remoring could be evaluated in 
this procedure. These observat ions would make pos- 
sible the selection of a drug with maximal  withdrawal 
reducing effects and  min imal  a taxia-producing effects. 
The major  l imi ta t ion on  the dura t ion  of the dependent  
state was the animals '  health, which deteriorated over 
the time of the experiment dur ing chronic adminis-  
t ra t ion  of ethanol.  It  would  be part icularly useful to 
devise a method  for main ta in ing  norma l  eating and  
dr inking behavior  while adminis ter ing ethanol  chroni- 
cally to primates. 
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